Session Information:
Session 1 (Clario session)
Applying AI to Pivotal Study Data – Managing Risk vs. Reward
In seemingly limitless ways, AI can help optimize clinical trial operations, enhance patient privacy, and improve data quality while reducing risk of human error. However, responsible deployment of AI is essential, to minimize risk for bias or hallucination adversely impacting critical data and decision making. Through specific examples, we will highlight Clario’s approach to responsibly developing and deploying dozens of AI-enabled tools in clinical trials today.
Track B: New Frontiers in Digital Tech Solutions
Date: Tuesday, September 16, 2025
Time: 12:05 pm – 12:15 pm ET
Speakers
Todd Rudo, M.D.
EVP and Chief Medical Officer at Clario
Dr. Todd Rudo is EVP and Chief Medical Officer at Clario, providing medical and scientific leadership across the organization. He has nearly 20 years of clinical cardiology and pharmaceutical research experience, with a career predominantly focused on drug safety.
Dr. Rudo has board certifications in cardiology, cardiac electrophysiology, nuclear cardiology, adult echocardiography and internal medicine. His team provides expert consulting to clients on scientific and regulatory strategy and ensures Clario’s product portfolio is scientifically robust, generating high-quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while maintaining focus on the customer experience, including minimizing patient and site burden.
Meet with us at DPHARM 2025.
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.